홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
AXSM
#937
Axsome Therapeutics, Inc
182.480
0
USD
+2.33%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+2.33%
월간 변동
+15.86%
6달 변화
+40.15%
년간 변동율
+40.15%
이전 종가
178.330
0
Open
182.620
0
Bid
Ask
Low
182.180
0
High
183.290
0
양
220
마켓
주식
헬스케어
AXSM
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.41 M
38.48 M
43.52 M
47.37 M
48.77 M
51.15 M
—
Valuation ratios
Enterprise value
2.91 B
1.42 B
3.08 B
3.45 B
4 B
9.16 B
25.79 B
Price to earnings ratio
—
—
-15.94
-14.62
-14.13
-49.63
-116.44
Price to sales ratio
—
—
—
12.94
10.51
14.23
48.13
Price to cash flow ratio
—
—
-25.58
-24.13
-31.57
-97.27
-245.63
Price to book ratio
—
—
27.21
18.33
71.1
102.9
162.79
EBITDA 비율에 대한 기업 가치
-28.89
—
-13.59
-18.94
-15.79
24.16
-217.49
Profitability ratios
Return on assets %
-0.55
-1.49
-0.56
-0.41
-0.51
-0.27
-0.29
Return on equity %
-0.9
-8.34
-1.71
-1.25
-5.04
-2.07
-2.74
Return on invested capital %
-4 013.51
-6 425.58
-1 305.05
-883.08
-958.26
-384.7
-389.67
Gross margin %
100
—
—
90.37
91.37
92.56
369.72
Operating margin %
7 950.31
—
—
-85.67
-72.74
-26.12
-112.1
EBITDA margin %
7 947.64
—
—
-63.68
-62.59
58.48
-13.43
Net margin %
8 251.77
—
—
-88.41
-74.47
-28.69
-123.08
Liquidity ratios
Quick ratio
—
—
2.5
3.52
2.04
1.48
6.46
Current ratio
7.85
3.75
2.54
3.63
2.11
1.55
6.72
Inventory turnover
—
—
1.2
2.68
2.16
2.17
2.43
Asset turnover
-0.01
—
0
0.59
0.67
1.01
1
Solvency ratios
Debt to assets ratio
0.27
0.57
0.29
0.32
0.33
0.2
0.98
Debt to equity ratio
0.44
3.18
0.86
0.98
3.31
1.6
9.32
Long term debt to total assets ratio
0.26
0.56
0.28
0.3
0.32
0.17
0.83
Long term debt to total equity ratio
0.42
3.14
0.86
0.93
3.17
1.33
7.95
Per share metrics
Operating cash flow per share
—
—
-2.87
-3.19
-2.68
-1.88
-1.9
EBIT per share
—
—
-5.65
-5.1
-5.86
-3.35
-3.37
EBITDA per share
—
—
-5.41
-3.79
-5.04
7.51
-0.4
Total debt per share
—
—
2.33
4.1
3.94
2.84
12.74
Cash per share
—
—
4.94
8.5
6.58
6.49
25.28
Net current asset value per share
—
—
6.04
11.1
10.12
11.84
44.12
Tangible book value per share
—
—
0.97
2.77
-0.04
0.72
1.37
Working capital per share
—
—
3.67
8.04
5.32
4.22
17.39
Book value per share
—
—
2.69
4.2
1.19
1.77
5.82
뉴스
Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists
Axsome Therapeutics Priced For Perfection Ahead Of Auvelity's Alzheimer's Decision (AXSM)
Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)
AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?
RBC캐피털, Axsome Therapeutics에 ’Outperform’ 등급 재확인
RBC Capital reiterates Axsome Therapeutics stock rating at Outperform
Axsome, 전략적 성장 계획 발표 (2026년)
Axsome Therapeutics at The Citizens Life Sciences Conference: Strategic Growth Plans
Axsome Therapeutics, Inc. (AXSM) Presents at Leerink Global Healthcare Conference 2026 Transcript
Axsome, 전략적 성장 및 과제 (Leerink 컨퍼런스)